Ponesimod
Ponesimod (ACT-128800) is a selective, orally active S1P1 receptor agonist that functions as an immunomodulator. It is used in research to investigate mechanisms of lymphocyte trafficking and has been studied in models of autoimmune diseases such as multiple sclerosis.
Product Specifications
CAS Number
854107-55-4
Product Name Alternative
ACT 128800, ACT128800, ACT-128800, Inhibitor, lymphocyte-mediated, Lysophospholipid Receptor, inhibit, inflammation, LPL, LPL Receptor, LPLReceptor, S1PReceptor, S1P Receptor, S1P1, Ponesimod
Field of Research
Pharmacology & Drug Discovery
Purity
98.01% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (4.34 mM) ; DMSO:235 mg/mL (509.79 mM) ; Ethanol:92 mg/mL (199.58 mM)
Smiles
CCC\N=C1/S\C (=C/c2ccc (OC[C@H] (O) CO) c (Cl) c2) C (=O) N1c1ccccc1C
Molecular Formula
C23H25ClN2O4S
Molecular Weight
460.97
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
